Clinical Trials Browser

Phase 2 × Hodgkin Disease × Biosimilar Pharmaceuticals × Clear all

NCT00003820 2017-04-20

Rituximab in Treating Patients With Hodgkin's Lymphoma

Phase 2 Completed

39 enrolled 9 charts

Hodgkin Disease, Lymphoma